MyMoneyMedic

Information Memorandum

August 2026

CONFIDENTIALITY AND IMPORTANT NOTICES

By accepting a copy of this Investment Information Memorandum, the recipient agrees that it shall not contact or discuss the contents of this memorandum with any officer, employee, supplier, customer, licensor, franchisee, or associate of My Money Medic without the prior consent of Conor Keenan. This Memorandum and further information is supplied on the terms set out above and on the terms contained in a confidentiality agreement entered into by the recipient, the terms of which incorporate the above conditions and contain restrictions on the use of the information, its disclosure, and the conduct of the recipient. The recipient acknowledges the foregoing, and it is hereby agreed that the terms of the confidentiality agreement are incorporated into and form part of these conditions.

INVESTMENT RISK STATEMENT Capital at Risk: Investing in My Money Medic involves significant risks. Investors may lose part or all of their invested capital. No Guarantees: Neither My Money Medic nor its directors guarantee any rate of return, repayment of investment, or successful achievement of planned objectives. Past Performance: Past performance is not indicative of future results. Investment outcomes may vary substantially from projections or expectations. External Factors: Market conditions, regulatory changes, operational challenges, and other factors beyond our control may adversely affect investment performance. The value of investments can fluctuate significantly. Investor Suitability: This investment opportunity is intended for wholesale and sophisticated investors who understand the risks associated with private company investment.

PLATFORM DISCLAIMER —BizDealRoom.com is a digital marketplace operated by Mentored Business Sales Services Pty Ltd (ABN 56 630 339 150), providing technology infrastructure only for connecting business owners, vendors, and capital seekers with potential investors, purchasers, and partners. BizDealRoom.com does not promote, endorse, recommend, or verify any listed opportunity. All information in this document has been provided solely by the business owner, who is acting independently and is solely responsible for its accuracy and content. BizDealRoom has not conducted due diligence on this opportunity and provides no financial, legal, accounting, or investment advice. Recipients must conduct their own independent due diligence and seek advice from appropriately qualified professionals before making any decision. To the maximum extent permitted by law, BizDealRoom.com, Mentored Business Sales Services Pty Ltd, and their directors, officers, employees, and agents accept no liability for any loss arising from reliance on information accessed through the Platform.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

CONFIDENTIALITY AND IMPORTANT NOTICES

INVESTMENT RISK STATEMENT Capital at Risk: Investing in My Money Medic involves significant risks. Investors may lose part or all of their invested capital. No Guarantees: Neither My Money Medic nor its directors guarantee any rate of return, repayment of investment, or successful achievement of planned objectives. Past Performance: Past performance is not indicative of future results. Investment outcomes may vary substantially from projections or expectations. External Factors: Market conditions, regulatory changes, operational challenges, and other factors beyond our control may adversely affect investment performance. The value of investments can fluctuate significantly. Investor Suitability: This investment opportunity is intended for wholesale and sophisticated investors who understand the risks associated with private company investment.

IMPORTANT NOTICE The information contained in this Investment Information Memorandum and any other verbal or written information given in respect of My Money Medic ("Information") is provided to the recipient ("you") on the following conditions. Accuracy: The officers, employees, or consultants of My Money Medic ("we, us") make no representation, warranty, or guarantee that the information is complete, accurate, or balanced. Some information has been obtained from third parties and has not been independently verified. No Warranty: No warranty, representation, or undertaking, whether express or implied, is made, and no responsibility is accepted by the business owner as to the accuracy of any part of this or any further information supplied. Visual Materials: All visual images, plans, photographs, and projections are indicative only and subject to change. Not Financial Advice: This document does not constitute, and should not be considered as, financial advice or a recommendation to invest. You must obtain independent legal, financial, and taxation advice before making any investment decision. Valuation: Neither the business owner nor BizDealRoom.com are valuers and no comment is made as to the value of the company or its shares.

PURPOSE OF THIS DOCUMENT Conor Keenan, in the capacity of director of My Money Medic 81681593724, has decided to seek investment for growth capital and has chosen to use the BizDealRoom.com platform operated by MENTORED BUSINESS SALES SERVICES PTY LTD (ABN 56 630 339 150) as a communication medium to connect with potential investors. Owner Responsibility: The business owner is solely responsible for all content in this memorandum. BizDealRoom.com has not prepared, verified, or endorsed this document or its contents. This Confidential Investment Information Memorandum has been prepared by the business owner for selected parties to assist the recipient in making their own independent appraisal before making any investment decision. The memorandum does not purport to be complete or contain all information that a prospective investor may require. All projections have been prepared by the company or their accountants and are subject to uncertainties and contingencies beyond our control. All currency amounts are expressed in Australian dollars unless otherwise stated.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

A MESSAGE FROM THE FOUNDER

When we started MyMoneyMedic.ai, the opportunity we saw was broader than budgeting. Financial stress rarely stays confined to a bank account. It can affect mental wellbeing, motivation, physical health, relationships and the quality of the decisions people make. Yet most financial tools continue to focus on transactions, balances and what has already happened.

I founded MyMoneyMedic.ai to build a different experience: one designed around the person, not simply their transaction history. Our approach connects four areas we describe as My Money, My Mind, My Body and My Life. By bringing those dimensions together, we aim to help people understand what is happening, identify what needs attention and take practical steps towards greater control.

We have now progressed beyond the original concept. We have developed and launched our MVP, built PulseCheck and financial tracking capabilities, introduced AI-powered guidance, progressed our Consumer Data Right and Open Banking capabilities and developed an enterprise proposition capable of supporting organisations as well as individual users. Our app launched across Apple and Google Play in January 2026, and our commercial focus is now shifting towards converting pilots, partnerships and our identified pipeline into recurring revenue.

What excites me most is the scale of what this platform can become. Our opportunity spans individual subscriptions, employers, professional associations, financial services, wellbeing providers, government-related programs and strategic partners. We have identified 7.5 million potential users within our Australian 2026/2027 pipeline landscape, while our longer-term roadmap extends beyond Australia into international markets.

We are seeking USD $1,000,000 of seed capital at a USD $10,000,000 pre-money valuation. For us, this raise is about turning the foundation already built into scalable commercial growth while continuing to improve the technology, intelligence and customer experience behind MyMoneyMedic.ai.

Our ambition is to make financial wellbeing more accessible, more proactive and more connected to the realities of people's lives.

Conor Keenan
Founder & CEO

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

EXECUTIVE SUMMARY

MyMoneyMedic.ai is an AI-powered financial wellbeing ecosystem combining financial data, behavioural insights, Open Banking, personalised guidance and human support. With an operational MVP, CDR/Open Banking capability, early users, partnerships and an identified Australian pipeline, we are now raising USD $1,000,000 to accelerate commercial scale.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

EXECUTIVE SUMMARY

MyMoneyMedic.ai, operated by NIOSMO GROUP PTY LTD, is an AI-powered financial wellbeing platform designed to help people understand, manage and improve their wellbeing across four interconnected pillars: My Money, My Mind, My Body and My Life. Established in 2024, we have developed an integrated platform combining financial information, behavioural insights, AI-powered guidance, wellbeing assessment and pathways to human support.

Our proposition addresses a clear problem: financial pressure can influence mental wellbeing, physical health, relationships, motivation and decision-making, while many existing solutions address only one component of that experience. MyMoneyMedic.ai connects these areas within a single ecosystem. PulseCheck assesses financial and broader wellbeing; interactive tools support budgeting, cashflow, goals and net worth; Open Banking enables connected financial information; our AI experience provides personalised guidance; and the Care Portal provides pathways to appropriate support.

Our business model combines consumer and enterprise distribution. Revenue opportunities identified in our source materials include B2C subscriptions, enterprise licensing, financial mentoring, consulting, referral relationships, advertising and partnerships, and potential white-label offerings. The August 2026 pitch deck also identifies a targeted individual ARPU of USD $4 per month and enterprise distribution through employers, clubs, financial institutions and industry bodies.

We have moved beyond concept stage. Our MVP is operational, the application launched on Apple and Google Play in January 2026, and we have progressed CDR/Open Banking capability alongside pilots, partnerships and an enterprise proposition. Management has identified a 2026/2027 Australian opportunity landscape representing 7.5 million potential users, with a goal of reaching 100,000 users by the end of 2027.

We are seeking USD $1,000,000 of seed investment at a USD $10,000,000 pre-money valuation, representing approximately 9.1% equity on a post-money basis. The investment structure may be negotiated through direct equity or a SAFE/convertible note subject to mutually agreed terms. Capital is intended to accelerate product development, commercial growth, customer acquisition, recruitment and operations as we scale initially in Australia and subsequently pursue international opportunities.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY



HISTORY AND KEY BUSINESS MILESTONES

Since establishment in 2024, we have progressed from initial concept and product architecture to an operational platform, public app launch, Open Banking/CDR capability and commercial validation. The next chapter is focused on converting this technical and product foundation into recurring revenue, broader enterprise adoption and scalable Australian distribution.




Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

HISTORY AND KEY BUSINESS MILESTONES

1

2024 — Foundation

Established with a clear mission: address financial stress by connecting it to broader wellbeing. From day one, we set out to build an integrated platform — not just another budgeting app.

2

2025 — Proof of Concept & MVP

Developed our proof of concept, product architecture and the four-pillar My Money, My Mind, My Body and My Life methodology. Built our MVP with PulseCheck, financial tracking and AI-powered insights.

3

January 2026 — App Launch

Launched MyMoneyMedic.ai on Apple and Google Play. Continued expanding budgeting, goals, cashflow and net worth features while progressing employee wellbeing and financial services relationships.

4

Q1–Q2 2026 — Open Banking & CDR

Achieved CDR certification and finalised Open Banking integration — enabling richer, connected financial insights and unlocking enterprise-grade data infrastructure.

5

Now — Commercial Validation

Active corporate pilots and strategic opportunities across employers, professional associations and financial institutions. Converting our technical foundation into recurring revenue and scalable distribution.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY



TYPICAL CUSTOMERS

Our addressable customer base spans individuals and organisations. Consumers use MyMoneyMedic.ai to gain greater visibility and practical support around money and wellbeing, while employers, clubs, professional organisations and other partners can use the platform to extend financial wellbeing support across established communities at scale.





Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

TYPICAL CUSTOMERS

We serve two primary customer groups: individual users seeking practical support with their financial and broader wellbeing, and organisations seeking a scalable way to support employees, members or participants.

For individual users, MyMoneyMedic.ai is designed around people who want greater visibility, structure and confidence in managing their financial lives. This includes working professionals, families and people seeking practical, personalised support rather than a platform limited to expense tracking. A user may want to understand spending, organise cashflow, build goals, assess net worth, work through financial pressure or determine what action should come next.

Our website reflects this broad use case. We encourage users to begin with the financial question they have been putting off, then use Alex to make sense of what is happening, sort priorities, understand available options and turn larger problems into manageable next steps. Users can connect and reflect, talk through their position, receive a plan, track progress and continue receiving support as circumstances change.

Our organisational customer proposition is structured around scalable distribution. Target organisations identified in the client materials include SMEs, larger employers, professional services businesses and organisations with significant workforces. MyMoneyMedic.ai can complement existing employee assistance, HR and workplace wellbeing programs rather than requiring employers to create a new internal financial coaching function.

The current website further identifies dedicated pathways for clubs, corporate organisations and government, with an emphasis on supporting people beyond the workplace or organisation while keeping personal financial information private from the organisations providing access.

Strategic distribution partners can include financial advisers, accountants, EAP providers, HR platforms, financial institutions and other professional service organisations. These relationships provide a pathway to reach existing client, employee and membership networks and underpin our B2B2C approach.

Our August 2026 target landscape extends across employers, insurance, wealth and investing, financial education, mortgage and lending, superannuation, SME finance, and health and financial wellbeing. Across these customer groups, the common need is consistent: an accessible platform capable of translating financial information and wellbeing signals into clearer understanding, practical actions and, where appropriate, pathways to additional human support.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

MEET THE TEAM

Our leadership combines founder-led product vision with dedicated commercial execution. Conor Keenan leads strategy, product direction, partnerships and growth, while Martin Morris leads sales, business development and enterprise acquisition. A lean technology model and specialist external partners support continued platform development and commercial expansion.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

MEET THE TEAM

Our management structure has been designed around the core priorities of an early-stage technology business moving into commercial scale: product vision, enterprise sales, technology development, strategic partnerships and efficient access to specialist capability.

Conor Keenan — Founder & CEO

Conor leads the overall vision and strategy for MyMoneyMedic.ai and is responsible for product direction, partnerships and business growth. As founder, his role connects the original financial wellbeing proposition with the platform's continued development and its transition from MVP into a broader B2C and B2B2C commercial model. Conor currently holds 90% of NIOSMO GROUP PTY LTD.

Martin Morris — Chief Sales Officer

Martin Morris is our Chief Sales Officer and holds 10% of NIOSMO GROUP PTY LTD. Martin leads sales, business development and enterprise customer acquisition. His focus is directly aligned with the next stage of our strategy: converting existing pilot, partnership and pipeline opportunities into scalable commercial relationships and recurring enterprise revenue.

Our technology and product function supports the continued development, security, AI capability and Open Banking infrastructure required by the platform. Rather than building a large fixed-cost organisation prematurely, we also use specialist technology resources to accelerate development where appropriate.

We complement our internal leadership with external expertise across accounting, R&D tax, financial services, technology and employee wellbeing. This structure gives us access to specialist capability while maintaining the lean operating model reflected in our current stage of development.

The next phase of team development is directly connected to the capital raise. Under our approved use-of-capital allocation, 20% of proceeds is intended for team and recruitment, with key hires anticipated across technology, sales, marketing and customer success. This investment is intended to add execution capacity as commercial activity expands without changing the founder-led strategic direction of the organisation.

Our management priorities are clear: strengthen the product, expand enterprise adoption, convert identified opportunities into recurring revenue, deepen strategic partnerships and build the organisational capabilities required to support Australian growth and future international expansion.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY



SWOT ANALYSIS

Our position combines an operational product, Open Banking/CDR capability, AI-powered guidance and an integrated financial and broader wellbeing proposition. The strategic task is now to translate those capabilities into repeatable commercial adoption while continuing product development and differentiating against established finance, banking and wellbeing platforms.



Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

SWOT ANALYSIS

STRENGTHS

Our primary strength is the breadth of the integrated proposition. MyMoneyMedic.ai combines financial data, Open Banking, AI-powered guidance, behavioural insights, wellbeing assessment and access to human support rather than limiting the experience to budgeting or transaction tracking. PulseCheck, financial dashboards, Alex and the Care Portal operate within a broader My Money, My Mind, My Body and My Life framework.

Our development position is another strength. We have an operational MVP, launched on both major app stores, and have progressed CDR/Open Banking capability. The August 2026 pitch deck positions that regulatory and data infrastructure as a foundation for higher-quality financial insights and enterprise integration.


WEAKNESSES

Our current stage is early commercialisation rather than mature scale. The principal execution requirement identified in our source materials is converting pilots, partnerships and pipeline opportunities into predictable recurring revenue and scalable customer growth. Our current team is deliberately lean, with future recruitment required across technology, sales, marketing and customer success as adoption expands.


Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

SWOT ANALYSIS (CONTINUED)

OPPORTUNITIES

Our opportunity spans both direct consumer monetisation and organisation-led distribution. The business model includes subscriptions, enterprise licensing, mentoring, consulting, referrals, advertising and partnerships, with potential white-label solutions. Our B2B2C strategy provides the opportunity to reach large populations through employers, clubs, professional associations, financial services organisations and other strategic partners.

Management has identified a 2026/2027 Australian opportunity landscape representing 7.5 million users, with a target of 100,000 users by the end of 2027. The longer-term roadmap also contemplates localisation, multi-language capability, additional banking integrations and international deployment.


THREATS

We operate across categories containing established finance applications, banks, fintech platforms and employee assistance providers. Competitors already offer functionality including Open Banking, account aggregation, budgeting, financial forecasting, credit monitoring and workplace wellbeing services. Continued differentiation therefore depends on executing our integrated financial-and-overall-wellbeing proposition, maintaining product relevance and successfully building distribution.

Our strategy is designed around that distinction: using connected financial information and AI not simply to report historical activity, but to support practical action, behavioural improvement and appropriate pathways to human care.


Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY



OUR PRODUCTS

MyMoneyMedic.ai brings financial understanding, AI-guided action and broader wellbeing support into one connected experience. Our product suite combines PulseCheck, Open Banking, dashboards, budgeting and goal tools, Alex, progress tracking and the Care Portal, while our enterprise model makes those capabilities available through organisational and partner distribution.




Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

Introducing MyMoneyMedic

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

OUR PRODUCTS

Our core product is an AI-powered financial wellbeing platform built to help users understand their financial position, decide what requires attention and take practical action. The experience is designed around a simple progression: connect, review, plan and track.

PulseCheck provides an assessment of financial and broader wellbeing and supports personalised wellbeing scoring. Financial management capabilities include interactive dashboards, budgeting, cashflow monitoring, net worth tracking and goal management. Open Banking connectivity allows users to bring financial account information into the platform and receive insights based on connected financial data.

Alex is our AI-powered financial wellbeing experience. Our August 2026 pitch deck describes Alex as a proactive, always-available financial coach designed to identify issues and support users before financial pressure develops further. The current MyMoneyMedic.ai website positions Alex as a private place to work through questions, organise priorities, understand options, break larger issues into smaller next steps and build practical money habits. Our broader model extends beyond money management. The four pillars — My Money, My Mind, My Body and My Life — recognise that financial stress can influence mental wellbeing, motivation, sleep, physical wellbeing, relationships and decision-making. This framework enables us to place financial information within the broader context of the user's life.

Where digital guidance alone is not sufficient, the Care Portal provides access to relevant professional and wellbeing support. Our website describes this as a pathway for circumstances involving areas such as mental health, gambling, relationships, housing or family stress, with users choosing whether and how they seek further assistance.

For organisations, we provide a scalable financial wellbeing proposition suitable for corporate, club, government and other organisational settings. The client materials also identify enterprise licensing, mentoring, consulting, referrals and potential white-label solutions.

The resulting product architecture connects technology and human support: financial information provides context, AI helps translate that context into personalised actions, progress tools encourage engagement, and the support ecosystem creates a pathway beyond the application when additional help is appropriate.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

OUR PRODUCTS

Future B2B Expansion: Verisource Global Compliance Engine

Beyond the core MyMoneyMedic financial wellbeing ecosystem, the company's underlying tech architecture powers Verisource Global—a dedicated B2B regulatory compliance application tailored for the Australian market.

Market Driver:

Built to directly address AUSTRAC's expanded AML/CTF (Tranche 2) regulatory obligations impacting Australian professional service providers.

Target Industries:

High-risk "gatekeeper" service providers across legal, real estate, accounting, finance, banking, and gaming sectors.

Key Capability:

Offers an automated, simple, and economical compliance solution covering Customer Due Diligence (CDD), swift identity verification, and streamlined regulatory reporting to minimize business friction and exposure to non-compliance penalties.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY



COMPETITOR ANALYSIS

We compete across personal finance, Open Banking, budgeting, financial comparison and employee wellbeing rather than within a single narrow category. Established platforms demonstrate strong demand for individual components of the proposition. Our differentiation is the combination of connected financial data, AI guidance, behavioural support and broader wellbeing pathways in one ecosystem.



Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

COMPETITOR ANALYSIS

The competitive landscape for MyMoneyMedic.ai spans several categories because our proposition combines capabilities that are commonly offered separately.

Frollo

Frollo is a significant Australian Open Banking and money-management competitor. Its consumer platform connects accounts through the Consumer Data Right and provides transaction categorisation, budgets, goals, net worth, recurring-bill monitoring and AI-driven personalisation. Frollo states that it is an Accredited Data Recipient and positions Open Banking as central to its consumer financial-management experience.

WeMoney

WeMoney is positioned as an Australian social financial wellness application. Its current product includes connected financial accounts, budgets, transaction categorisation, bills, goals, net worth, credit-score monitoring, financial product offers and community functionality. Its commercial positioning therefore overlaps strongly with consumer financial visibility and action, but its public product proposition centres primarily on money management, debt, credit and financial-product optimisation.

PocketSmith

PocketSmith competes particularly strongly in detailed personal-finance management and forecasting. Its platform provides bank feeds, transaction management, budgeting, dashboards, net-worth reporting, what-if scenarios and long-range cashflow forecasting. Its positioning is particularly relevant for users seeking deep forward-looking financial modelling.

YNAB

YNAB has built its proposition around intentional spending and a structured budgeting methodology. Its system focuses on assigning available money to priorities, planning for future expenditure, funding goals and adjusting the plan as circumstances change. This represents a strong behaviour-led budgeting proposition, although it is structurally different from our broader financial-and-wellbeing ecosystem.

Finder

Finder provides another form of competition through financial comparison, credit-score services and money-management functionality. Finder is an accredited CDR data recipient and has offered connected-account budgeting capabilities alongside its broader financial-product comparison model.

Our differentiation is therefore not based on claiming that competitors lack sophisticated financial tools. It is based on how we combine them. MyMoneyMedic.ai brings financial information, AI-powered guidance, behavioural insights, broader wellbeing monitoring and pathways to human support together within the four-pillar My Money, My Mind, My Body and My Life model.

This creates a proposition positioned between personal financial management and broader wellbeing support, with both direct-to-consumer and organisation-led distribution.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY




ROADMAP AND GROWTH OPPORTUNITIES

Our roadmap moves from Australian product-market validation to partner-led distribution and, subsequently, international expansion. The immediate focus is product enhancement, enterprise conversion and recurring revenue. Longer term, our source materials envisage localised AI, multi-language deployment, broader banking integration and expansion into regulated international markets.



Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

ROADMAP AND GROWTH OPPORTUNITIES

Our current roadmap is structured around three stages: prove, expand and scale.

1

Prove

The first stage is focused on Australia. We are strengthening Open Banking/CDR connectivity, expanding AI-powered financial insights and recommendations, and continuing development across budgeting, cashflow, goals, net worth, subscription tracking and personalised guidance. At the commercial level, our priority is converting pilots, partnerships and identified pipeline opportunities into recurring B2B revenue while continuing to build consumer adoption.

2

Expand

The second stage centres on partner-led growth. Our source materials identify distribution opportunities through employers, professional associations, banks and insurers, government-related channels, EAP providers and strategic partners. We also intend to expand potential white-label applications for organisations seeking to integrate financial wellbeing into existing employee, member or customer propositions.

3

Scale

Our third stage is international expansion. The pitch deck identifies future localisation, multi-language capability, international banking integrations and country-ready deployment, with target markets illustrated across Australia, New Zealand, the United States, Canada, the United Kingdom and the European Union.


The strategic direction is therefore sequential: validate and commercialise locally, use organisational distribution to build scale, then extend the platform into international markets.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

GROWTH OPPORTUNITIES



10,000 in 2026

USD $0.6 million

100,000 in 2027

USD $5.1 million

400,000 in 2028

USD $19.2 million

1 million in 2029

USD $49.5 million

1.75 million in 2030

USD $87.7 million

3 million in 2031

USD $148.6 million


Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY




USE OF CAPITAL

We are raising USD $1,000,000 to accelerate the transition from an operational product and identified commercial pipeline into scalable growth. Capital will be allocated across product and technology, sales and marketing, team expansion and operations, with the largest allocation directed towards the technology, AI and Open Banking capabilities underpinning the platform.



Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

USE OF CAPITAL

We are seeking USD $1,000,000 of seed investment at a USD $10,000,000 pre-money valuation, representing approximately 9.1% equity on a post-money basis. The investment structure may be negotiated, including direct equity or a SAFE/convertible note, subject to mutually agreed terms.

Our intended allocation of capital is:

PRODUCT & TECHNOLOGY — 40%

USD $400,000 is intended for continued product and technology development. Priorities identified in the client materials include Open Banking/CDR capabilities, AI development, platform enhancements and security. This investment supports the continued evolution of MyMoneyMedic.ai from its current operational MVP into a more sophisticated and scalable financial wellbeing platform.

SALES & MARKETING — 30%

USD $300,000 is intended for commercial growth. The focus is B2B customer acquisition, strategic partnerships, brand awareness and lead generation. This allocation directly supports our objective of converting existing pilots, partnerships and the identified opportunity pipeline into enterprise relationships and recurring revenue.

TEAM & RECRUITMENT — 20%

USD $200,000 is intended for team expansion, with key hires anticipated across technology, sales, marketing and customer success. Our current model combines founder-led management, commercial leadership, internal technology/product capability and external specialist resources. Additional recruitment is intended to increase execution capacity as product adoption and enterprise activity expand.

OPERATIONS — 10%

USD $100,000 is intended for compliance, infrastructure, professional services and general operating requirements. This allocation supports the operational foundation required to scale product delivery and commercial activities.

Collectively, the use of capital is designed to address the next stage of our development rather than fund initial concept creation. We already have an operational MVP, early users, partnerships and CDR/Open Banking capability. The purpose of the raise is to accelerate the conversion of that foundation into recurring revenue, broader adoption and a scalable commercial model.

Our immediate focus remains the Australian market. Capital will support growth in users and enterprise customers, continued development of the platform and the team and infrastructure required to execute our strategy. As the Australian model becomes established, our roadmap provides for subsequent international expansion.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

FINANCIALS

FORWARD-LOOKING STATEMENTS

The financial projections presented in this section, including forecast user growth, revenue, EBITDA, distributions and DCF enterprise value, are based on management’s current expectations, estimates and assumptions. Forward-looking statements are subject to business, financial, operational, regulatory and market risks and uncertainties. Actual results may differ materially, and no representation, warranty or guarantee is given that any projection, target or valuation will be achieved. The projections have not been independently audited, and the DCF enterprise values are indicative estimates rather than current or guaranteed future valuations.



Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

User growth model

A quantified pathway from 10,000 initial users to 3 million users, supported by increasing revenue and EBITDA.


Forecast user growth

Total users

Corresponding forecast revenue

USD millions

Forecast EBITDA

USD millions, figures provided through 2029

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

FINANCIAL OUTLOOK

Four-year trajectory across users, revenue, EBITDA, distributions and DCF enterprise value.



Revenue and EBITDA

$m millions

Forecast distributions

$m millions, no value shown for 2026


DCF enterprise value progression

$m millions, no value shown for 2026

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

HOW TO INVEST

HOW TO INVEST

  • Investment Amount: Minimum subscription sizing subject to negotiation based on total round allocation.
  • Investment Structure: Direct equity issuing ordinary shares, or a Simple Agreement for Future Equity (SAFE) / Convertible Note with terms agreed upon engagement.
  • Investor Eligibility: Open exclusively to wholesale and sophisticated investors under Section 708 of the Australian Corporations Act 2001 (or relevant international equivalent).

Direct Founder & Management Contact

Please direct all inquiries, subscription requests, and due diligence questions directly to the My Money Medic team:

NIOSMO GROUP PTY LTD (ABN 81 681 593 724)

Conor Keenan | Founder & CEO

Phone: +61 416 038 455

  1. Submit Expression of Interest (EOI): Contact the My Money Medic executive team directly via email at conor@mymoneymedic.ai to register your interest.
  1. Access Data Room & Due Diligence: Upon signing a Non-Disclosure Agreement (NDA) directly with My Money Medic and confirming wholesale investor verification, access will be granted to detailed financial models, cap table details, and technical documentation.
  1. Management Discussion: Schedule a 1-on-1 discussion directly with Conor Keenan (Founder & CEO) to review strategic alignment, allocation size, and investment terms.
  1. Term Sheet & Documentation Execution: Review and execute the binding Term Sheet and formal Subscription Agreement directly with My Money Medic leadership.
  1. Settlement & Issuance: Transfer funds directly to the designated My Money Medic company account upon execution. Share certificates or note instruments will be issued following settlement.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY

CONTACT DETAILS AND THANKS

Thank you for considering the MyMoneyMedic.ai investment opportunity.

We are seeking USD $1,000,000 in seed funding at a USD $10,000,000 pre-money valuation, representing approximately 9.1% equity on a post-money basis.

NIOSMO GROUP PTY LTD
ABN 81 681 593 724

Conor Keenan

Founder & CEO

Email: conor@mymoneymedic.ai
Phone: 0416 038 455
Website: https://mymoneymedic.ai/

We welcome engagement with investors and strategic partners who can contribute capital, expertise, industry relationships and access to corporate, financial services and wellbeing markets as we move into our next stage of commercial growth.

Version 1.0 – August 2026

CONFIDENTIAL FOR WHOLESALE & SOPHISTICATED INVESTORS ONLY